Decision making in clinical trials: Interim analyses, innovative design, and biomarkers

Abstract The efficient and accurate execution of clinical trials testing novel treatments for Alzheimer's disease (AD) is a critical component of the field's collective efforts to develop effective disease‐modifying treatments for AD. The lengthy and heterogeneous nature of clinical progression in A...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kathleen A. Welsh‐Bohmer, Geoffrey A. Kerchner, Shobha Dhadda, Miguel Garcia, David S. Miller, Fanni Natanegara, Lars Lau Raket, Weining Robieson, Eric R. Siemers, Maria C. Carrillo, Christopher J. Weber
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-10-01
coleção:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Assuntos:	Alzheimer's disease amyloid clinical meaningfulness clinical trial cognition cognitive impairment
Acesso em linha:	https://doi.org/10.1002/trc2.12421
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!